Royal Bank of Canada »

Gyre Therapeutics Incorporated shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $91k 12k 7.34
2025-06-30 $0 6.3k 0.00
2025-03-31 $0 392 0.00
2024-12-31 $10k 810 12.35
2024-09-30 $11k 964 11.33
2024-06-30 $13k 1.1k 12.63

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Gyre Therapeutics Incorporated

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
SBI Securities
Charles Schwab Investment Management
Northern Trust
State of Wisconsin Investment Board
Millennium Management
Morgan Stanley
Bank of New York Mellon
UBS Group
Alliancebernstein
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Goldman Sachs Group

View all funds holding Gyre Therapeutics Incorporated